Jason Butler analyst JMP

Currently out of the existing stock ratings of Jason Butler, 187 are a BUY (94.44%), 10 are a HOLD (5.05%), 1 are a SELL (0.51%).

Jason Butler

Work Performance Price Targets & Ratings Chart

Analyst Jason Butler works at JMP with a stock forecast success ratio of 38.83% fulfilled within 168 days on average.

Jason Butler’s has documented 386 price targets and ratings displayed on 41 stocks. The coverage is on Healthcare, Industrials sectors.

Most recent stock forecast was given on HALO, Halozyme Therapeutics at 21-Feb-2024.

Wall Street Analyst Jason Butler

Analyst best performing recommendations are on TRVN (TREVENA).
The best stock recommendation documented was for HALO (HALOZYME THERAPEUTICS) at 2/24/2021. The price target of $48 was fulfilled within 1 day with a profit of $3.45 (6.71%) receiving and performance score of 67.06.

Average potential price target upside

ACAD ACADIA Pharmaceuticals ADMS Adamas Pharmaceuticals ARGX argenx NV ADR ARNA Arena Pharmaceuticals AXGT Sio Gene Therapies CRMD CorMedix CYTK Cytokinetics ESPR Esperion Therapeutics HALO Halozyme Therapeutics ITCI Intracellular Th KRTX Karuna Therapeutics NEOS Neos Therapeutics NERV Minerva Neurosciences RZLT Rezolute SYRS Syros Pharmaceuticals VNDA Vanda Pharmaceuticals XON Precigen ZFGN Zafgen MYOV Myovant Sciences Ltd PLXP PLx Pharma AMTI Applied Molecular Transport  AQST Aquestive Therapeutics ATHA Athira Pharma  AXON Axon Enterprise . CRTX Cortexyme ENTA Enanta Pharmaceuticals HOOK Hookipa Pharma LRMR Larimar Therapeutics PGEN Precigen GMDA Gamida Cell Ltd MRNS Marinus Pharmaceuticals CNCE Concert Pharmaceuticals MOR MorphoSys AG ADR OVID Ovid Therapeutics PRTO Proteon Therapeutics QNRX Quoin Pharmaceuticals Ltd DRC TRVN Trevena VRDN Viridian Therapeutics ZGNX Zogenix GHRS GH Research PLC PRTA Prothena plc

Analyst name

Rating

Current price target

Potential distance

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

42

$17.15 (69.01%)

42

19 days ago

9/15 (60%)

$16.26 (63.17%)

265

Buy

42

$17.15 (69.01%)

42

21 days ago

24/31 (77.42%)

$15.86 (60.67%)

506

Hold

25

$0.15 (0.60%)

25

21 days ago

13/14 (92.86%)

$-1.14 (-4.36%)

70

Hold

37

$12.15 (48.89%)

1 months 2 days ago

0/1 (0%)

$8.85 (31.44%)

Hold

37

$12.15 (48.89%)

1 months 2 days ago

2/4 (50%)

$8.85 (31.44%)

483

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

Which stock is Jason Butler is most bullish on?

Potential upside of $57.78 has been obtained for PRTA (PROTHENA PLC)

Which stock is Jason Butler is most reserved on?

Potential downside of -$2.25 has been obtained for KRTX (KARUNA THERAPEUTICS)

What Year was the first public recommendation made by Jason Butler?

On 2011

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?